Patients with Chronic Inflammatory Rheumatic diseases (CIRD) are at increased risk of
cardiovascular disease (CVD), ascribed not only to classical risk factors, but also to the …

Heightened rates of both cardiovascular (CV) events and subclinical atherosclerosis,
documented by imaging and vascular function techniques are well established in systemic …

Autoimmune diseases (AD) represent a broad spectrum of chronic conditions that may afflict
specific target organs or multiple systems with a significant burden on quality of life. These …

Background and objective Cardiovascular diseases (CVD) are the leading causes of death
in chronic inflammatory rheumatic diseases and are not solely explained by the increased …

The increased cardiovascular (CV) risk among patients with autoimmune rheumatic
diseases, such as arthritides and connective tissue diseases, has been extensively …

ABSTRACT Introduction: The metabolic syndrome (MetS) is now recognized as a chronic
proinflammatory and prothrombotic state that aggravates insulin resistance, oxidative injury …

Cardiovascular disease (CVD) is a major cause of death in systemic lupus erythematosus
(SLE) patients. Although the risk for cardiovascular events in patients with SLE is significant …

Systemic lupus erythematosus is a multiorgan autoimmune disease with a highly variable
clinical course, typically involving women in childbearing age. At present, many aspects of …

Purpose To conduct a systematic review and meta‐analysis assessing the prevalence of
metabolic syndrome (MetS) in patients with systemic lupus erythematosus (SLE) and the …

Objectives Metabolic syndrome (MetS) is highly prevalent in patients with systemic lupus
erythematosus (SLE) and it has been associated with increased cardiovascular risk. We …